Atlas Trials

Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes

Clinical trial NCT03254368 · COMPLETED

Trial details

NCT number
NCT03254368
Sponsor
Zafgen, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusOverweight and Obesity
Start date
2017-09-12
Primary completion
2018-11-12
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.